Works Cited

1. Podrid PJ, Kowey PR. Cardiac Arrhythmia: Mechanisms, Diagnosis, and Management. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001.

2. Eckardt L, Haverkamp W, Breithardt G. Antiarrhythmic therapy in heart failure. Heart Fail Monit. 2002;2(4):110-119.

3. Saliba WI, Natale A. Ventricular tachycardia syndromes. Med Clin North Am. 2001;85(2):267-304.

4. Tracy CM, Epstein AE, DiMarco JP, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6-e75.

5. Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2018;72(4):e91-e220.

6. Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Eur Heart J. 2015;36:2793-2867.

7. Curtis AB. Demise of the routine electrophysiologic study for survivors of life-threatening ventricular arrhythmias. Am Heart J. 2002;144(3):380-382.

8. Bing Liem L. Implantable Cardioverter-Defibrillator: A Practical Manual. Boston, MA: Kluwer Academic Publishers; 2001.

9. Brodsky MA, Mitchell LB, Halperin BD, Raitt MH, Hallstrom AP. Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial. Am Heart J. 2002;144(3):478-484.

10. American Heart Association. 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132(18 Suppl 2):S315-S573.

11. Grauer K. A Practical Guide to ECG Interpretation. 2nd ed. St Louis, MO: Mosby; 1998.

12. Toth P, Cannon CP. Comprehensive Cardiovascular Medicine in the Primary Care Setting. New York, NY: Springer Science Business Media; 2010.

13. Woods SL, Froelicher ES, Motzer SA, Bridges EJ. Cardiac Nursing. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2010.

14. Conover MB. Understanding Electrocardiography. 8th ed. St Louis, MO: Mosby; 2002.

15. Ashley EA, Niebauer J. Cardiology Explained. London: Remedica; 2004.

16. Dubin D. Rapid Interpretation of EKGs. 6th ed. Tampa, FL: Cover Publishing Company; 2004.

17. Mayo Clinic Staff. Heart Arrhythmia: Symptoms. Available at https://www.mayoclinic.org/diseases-conditions/heart-arrhythmia/symptoms-causes/syc-20350668. Last accessed November 9, 2020.

18. Bennet DH. Cardiac Arrhythmias: Practical Notes in Interpretation and Treatment. 7th ed. London: Hodder Arnold; 2006.

19. Wagner GS. Marriott's Practical Electrocardiography. 12th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2013.

20. Keany JE. Premature Ventricular Contraction. Available at https://emedicine.medscape.com/article/761148-overview. Last accessed November 9, 2020.

21. MedlinePlus. Ventricular Tachycardia. Available at https://medlineplus.gov/ency/article/000187.htm. Last accessed November 9, 2020.

22. Compton SJ. Ventricular Tachycardia. Available at https://emedicine.medscape.com/article/159075-overview. Last accessed November 9, 2020.

23. Chapman M, Hargreaves M, Schneider H, Royle M. Bidirectional ventricular tachycardia associated with digoxin toxicity and with normal digoxin levels. Short Comm. 2014;11(7):1222-1225.

24. Merck Manuals. Ventricular Tachycardia (VT). Available at https://www.merckmanuals.com/home/heart-and-blood-vessel-disorders/abnormal-heart-rhythms/ventricular-tachycardia. Last accessed November 9, 2020.

25. Weigner MJ, Buxton AE. Nonsustained ventricular tachycardia: a guide to the clinical significance and management. Med Clin North Am. 2001;85(2):305-320.

26. Pezeshkian NG. Accelerated Idioventricular Rhythm. Available at https://emedicine.medscape.com/article/150074-overview. Last accessed November 9, 2020.

27. Bosen DM, Flemming MA. Electrophysiologic testing. Dimens Crit Care Nurs. 2003;22(1):10-19.

28. Thaler MS. The Only EKG Book You'll Ever Need. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2015.

29. Koplan BA, Stevenson WG. Ventricular tachycardia and sudden cardiac death. Mayo Clin Proc. 2009;84(3):289-297.

30. Habash-Bseiso DE, Rokey R, Berger CJ, Weier AW, Chyou PH. Accuracy of noninvasive ejection fraction measurement in a large community-based clinic. Clin Med Res. 2005;3(2):75-82.

31. Nguyen VQ, Celebi MM, Suleman A, Sander GE. Dilated Cardiomyopathy. Available at https://emedicine.medscape.com/article/152696-overview. Last accessed November 9, 2020.

32. Brieler J, Breeden MA, Tucker J. Cardiomyopathy: an overview. Am Fam Physician. 2017;96(10):640-646.

33. Braunwald E, Zipes DP, Libby P, Bonow R. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 9th ed. Philadelphia, PA: Elsevier; 2012.

34. American Heart Association. Hypertrophic Cardiomyopathy (HCM). Available at https://www.heart.org/en/health-topics/cardiomyopathy/what-is-cardiomyopathy-in-adults/hypertrophic-cardiomyopathy. Last accessed November 9, 2020.

35. Diez P, Brugada J. How to recognize and manage idiopathic ventricular tachycardia. Eur Soc Cardiol. 2010;8(25).

36. Dave J. Torsade de Pointes. Available at https://emedicine.medscape.com/article/1950863-overview#aw2aab6b5. Last accessed November 9, 2020.

37. Lexicomp Online. Available at https://online.lexi.com/lco/action/login. Last accessed November 9, 2020.

38. Sovari AA, Kocheril AG, Assadi R, Baas AS. Long QT Syndrome. Available at https://emedicine.medscape.com/article/157826-overview. Last accessed November 9, 2020.

39. MedlinePlus. Ventricular Fibrillation. Available at https://medlineplus.gov/ency/article/007200.htm. Last accessed November 9, 2020.

40. Goyal SK, Rottman JN. Ventricular Fibrillation. Available at https://emedicine.medscape.com/article/158712-overview. Last accessed November 9, 2020.

41. Cummins RO, Ornato JP, Thies WH, Pepe PE. Improving survival from sudden cardiac arrest: the "chain of survival" concept: a statement for health professionals from the Advanced Cardiac Life Support Subcommittee and the Emergency Cardiac Care Committee, American Heart Association. Circulation. 1991;83(5):1832-1847.

42. American Heart Association. Out-of-Hospital Chain of Survival. Available at https://cpr.heart.org/en/resources/cpr-facts-and-stats/out-of-hospital-chain-of-survival. Last accessed November 9, 2020.

43. American Heart Association. 2020 American Heart Association Guidelines for CPR and ECC. Available at https://cpr.heart.org/en/resuscitation-science/cpr-and-ecc-guidelines. Last accessed November 9, 2020.

44. Aufderheide TP, Stapleton E, Hazinski MF, Cummins R. Instructor's Manual: Heartsaver AED. Dallas, TX: American Heart Association; 1998.

45. Koster RW. Automatic external defibrillator: key link in the chain of survival. J Cardiovasc Electrophysiol. 2002;13(1 Suppl): S92-S95.

46. Cardiac Monitoring.com. What is Mobile Cardiac Telemetry? Available at http://cardiacmonitoring.com/patient-information/what-is-mobile-cardiac-telemetry. Last accessed November 9, 2020.

47. Martinez-Rubio A, Kanaan N, Borggrefe M, et al. Advances for treating in-hospital cardiac arrest: safety and effectiveness of a new automatic external cardioverter-defibrillator. J Am Coll Cardiol. 2003;41(4):627-632.

48. American Heart Association. What Is an Automated External Defibrillator? Available at https://www.heart.org/-/media/data-import/downloadables/3/1/c/pe-abh-what-is-an-automated-external-defibrillator-ucm_300340.pdf. Last accessed November 9, 2020.

49. Beinart SC. Synchronized Electrical Cardioversion. Available at https://emedicine.medscape.com/article/1834044-overview. Last accessed November 9, 2020.

50. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. J Am Coll Cardiol. 2019;74:104-132.

51. Karliner LS, Jacobs EA, Chen AH, Mutha S. Do professional interpreters improve clinical care for patients with limited English proficiency? A systematic review of the literature. Health Serv Res. 2007;42(2):727-754.

52. Ngo-Metzger Q, Massagli MP, Clarridge BR, et al. Linguistic and cultural barriers to care: perspectives of Chinese and Vietnamese immigrants. J Gen Intern Med. 2003;18(1):44-52.

53. National Heart, Lung and Blood Institute. Holter and Event Monitors. Available at https://www.nhlbi.nih.gov/health-topics/holter-and-event-monitors. Last accessed November 9, 2020.

54. Medtronic. Daily Living: Pacemakers. Available at https://www.medtronic.com/uk-en/patients/treatments-therapies/pacemaker/living-with/daily-living.html. Last accessed November 9, 2020.

55. Heart Rhythm Society. Atrial Fibrillation. Available at https://upbeat.org/heart-rhythm-disorders/atrial-fibrillation#axzz3Iz01qUAn. Last accessed November 9, 2020.

56. Medtronic. Mobile Cardiac Telemetry (MCT). Available at https://www.medtronic.com/us-en/patients/treatments-therapies/heart-monitors/monitoring.html. Last accessed November 9, 2020.

57. Peters RW, Gold MR. Implantable cardiac defibrillators. Med Clin North Am. 2001;85(2):343-367.

58. Beyerbach DM. Pacemakers and Implantable Cardioverter-Defibrillators. Available at https://emedicine.medscape.com/article/162245-overview#a1. Last accessed November 9, 2020.

59. Epstein AE, DiMarco JP, Ellenbogen KA, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6-e75.

60. Knight L, Livingston NA, Gawlinski A, DeLurgio DB. Caring for patients with third-generation implantable cardioverter defibrillators: from decision to implant to patient's return home. Crit Care Nurse. 1997;17(5):46-61.

61. White E. Patients with implantable cardioverter defibrillators: transition to home. J Cardiovasc Nurs. 2000;14(3):42-52.

62. Doughtery CM. The natural history of recovery following sudden cardiac arrest and internal cardioverter-defibrillator implantation. Prog Cardiovasc Nurs. 2001;16(14):163-168.

63. Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation. 2010;121(3):458-477.

64. Maskarinec SA, Thaden JT, Cyr DD, Ruffin F, Souli M, Fowler VG. The risk of cardiac device-related infection in bacteremic patients is species specific: results of a 12-year prospective cohort. Open Forum Infect Dis. 2017;4(3):ofx132.

65. Ben Abid F, Al-Saoub H, Howadi F, Aibishawi A, Thapur M. Delayed pacemaker generator pocket and lead primary infection due to Burkholderia Cepacia. Am J Case Rep. 2017;18:855-858.

66. Mayo Clinic. Implantable Cardioverter-Defibrillators (ICDs). Available at https://www.mayoclinic.org/tests-procedures/implantable-cardioverter-defibrillators/about/pac-20384692. Last accessed November 9, 2020.

67. Steinke EE. Sexual concerns of patients and partners after an implantable cardioverter defibrillator. Dimens Crit Care Nurs. 2003;22(2):89-96.

68. Ocampo CM. Living with an implantable cardioverter defibrillator: impact on the patient, family, and society. Nurs Clin North Am. 2000;35(4):1019-1030.

69. Bleakley JF, Akiyama T. Driving and arrhythmias: implications of new data. Card Electrophysiol Rev. 2003;7(1):77-79.

70. Akiyama T, Powell JL, Mitchell LB, Ehlert FA, Baessler C. Resumption of driving after life-threatening ventricular tachyarrhythmia. N Engl J Med. 2001;345(6):391-397.

71. Schulmeister L. Pacemakers and environmental safety: what your patient needs to know. Nursing. 1998;28(7):58-60.

72. Medtronic. Questions and Answers – Living With An Implantable Cardiac Device. Available at https://www.medtronic.com/uk-en/patients/treatments-therapies/defibrillator-icd/living-with/questions-answers.html. Last accessed November 9, 2020.

73. Al-Khadra AS. Implantation of pacemakers and implantable cardioverter defibrillators in orally anticoagulated patients. Pacing Clin Electrophysiol. 2003;26(1 Pt 2):511-514.

74. Swerdlow CD, Friedman PA. Advanced ICD troubleshooting: part II. Pacing Clin Electrophysiol. 2006;29(1):70-96.

75. Rosenqvist M, Beyer T, Block M, den Dulk K, Minten J, Lindemans F. Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. Circulation. 1998;98(7):663-670.

76. Korte T, Jung W, Spehl S, et al. Incidence of ICD lead system related complications during long-term follow-up: comparison of epicardial and endocardial electrode system. Pacing Clin Electrophysiol. 1995;18(11):2053-2061.

77. Braunschweig F, Boriani G, Bauer A, et al. Management of patients receiving ICD shocks: electrical storm. Europace. 2010;12(12):1673-1690.

78. Marill KA. Ventricular Fibrillation in Emergency Medicine. Available at https://emedicine.medscape.com/article/760832-overview. Last accessed November 9, 2020.

79. Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357(26):2657-2665.

80. Israel CW, Barold SS. Electrical storm in patients with an implanted defibrillator: a matter of definition. Ann Noninvasive Electrocardiol. 2007;12(4):375-382.

81. Credner SC, Klingenheben T, Mauss O, Sticherling C, Hohnloser SH. Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol. 1998;32(7):1909-1915.

82. Exner DV, Pinski SL, Wyse DG, et al. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation. 2001;103(16):2066-2071.

83. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med. 1989;321(6):406-412.

84. Domanski MJ, Zipes DP, Schron E. Treatment of sudden cardiac death: current understandings from randomized trials and future research directions. Circulation. 1997;95(12):2694-2699.

85. Borggrefe M, Haverkamp W, Breithardt G. Clinical implications of the CAMIAT, EMIAT and SWORD trials: a European perspective. Card Electrophysiol Rev. 1998;2(1):34-35.

86. Pratt CM. Clinical implications of the Survival with Oral D-Sotalol (SWORD) Trial: an investigation of patients with left ventricular dysfunction after myocardial infarction. Card Electrophysiol Rev. 1998;2(1):28-29.

87. Torp-Pedersen C, Møller M, Bloch-Thomsen PE, et al. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. N Engl J Med. 1999;341(12):857-865.

88. Steinberg JS, Martins J, Sadanandan S, et al. Antiarrhythmic drug use in the implantable defibrillator arm of the Antiarrhythmics Versus Implantable Defibrillators (AVID) study. Am Heart J. 2001;142(3):520-529.

89. Vaughan Williams EM. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol. 1984;24(4):129-147.

90. Williams ES, Viswanathan MN. Current and emerging antiarrhythmic drug therapy for ventricular tachycardia. Cardiol Ther. 2013;2(1):27-46.

91. Deglin JH, Vallerand AH, Sanoski CA. Davis's Drug Guide for Nurses. 17th ed. Philadelphia, PA: FA Davis Company; 2020.

92. RxList. Available at https://www.rxlist.com/script/main/hp.asp. Last accessed November 9, 2020.

93. Heidenreich PA, Keeffe B, McDonald KM, Hlatky MA. Overview of randomized trials of antiarrhythmic drugs and devices for prevention of sudden cardiac death. Am Heart J. 2002;144(3):422-430.

94. Daily Med. Available at https://dailymed.nlm.nih.gov/dailymed/index.cfm. Last accessed November 9, 2020.

95. Greenberg ML. Catheter Ablation. Available at https://emedicine.medscape.com/article/1828541-overview. Last accessed November 9, 2020.

96. Tung R, Boyle NG, Shivkumar K. Catheter ablation of ventricular tachycardia. Circulation. 2010;122:e389-e391.

97. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina—summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol. 2003;41(1):159-168.

98. Fraker TD Jr, Fihn SD, Gibbons RJ, et al. 2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to Develop the Focused Update of the 2002 Guidelines for the Management of Patients with Chronic Stable Angina. Circulation. 2007;116(23):2762-2772.

99. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: Endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154-e235.

100. Jessup M, Abraham WT, Casey DE, et al. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults. J Am Coll Cardiol. 2009;53(15):1343-1382.

101. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009;119(14):e391-e479.

102. Cleveland Clinic. Left Ventricular Reconstructive Surgery. Available at https://my.clevelandclinic.org/health/treatments/16938-left-ventricular-reconstructive-surgery-modified-dor-procedure. Last accessed November 9, 2020.

103. Wellens F, Geelen P, Demirsoy E, et al. Surgical treatment of tachyarrhythmias due to postinfarction left ventricular aneurysm with endoaneurysmorrhaphy and cryoablation. Eur J Cardiothorac Surg. 2002;22(5):771-776.

104. Di Donato M, Sabatier M, Dor V, RESTORE Group. Surgical ventricular restoration in patients with postinfarction coronary artery disease: effectiveness on spontaneous and inducible ventricular tachycardia. Semin Thorac Cardiovasc Surg. 2001;13(4):480-485.

105. Daubert JC, Leclercq C, Mabo P. Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator. Europace. 2009;11(Suppl 5):v87-v92.

106. U.S. Food and Drug Administration. Automated External Defibrillators (AEDs). Available at https://www.fda.gov/medical-devices/cardiovascular-devices/automated-external-defibrillators-aeds. Last accessed November 9, 2020.

107. U.S. Food and Drug Administration. Press Release. FDA Reaches Agreement with Automatic External Defibrillator Manufacturer Over Quality Control Issues. Available at https://www.fda.gov/news-events/press-announcements/fda-reaches-agreement-automatic-external-defibrillator-manufacturer-over-quality-control-issues. Last accessed November 9, 2020.

108. Heart Failure Society of America. Executive summary: HFSA 2010 comprehensive heart failure practice guideline. J Cardiac Failure. 2010;16(6):475-539.

109. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017;1-75.

Evidence-Based Practice Recommendations Citations

1. National Institute for Health and Care Excellence. Implantable Cardioverter Defibrillators and Cardiac Resynchronization Therapy for Arrhythmias and Heart Failure (Review of TA95 and TA120). London: National Institute for Health and Care Excellence; 2014. Available at https://www.nice.org.uk/guidance/ta314/documents/arrythmias-icds-heart-failure-cardiac-resynchronisation-fad-document2. Last accessed December 8, 2020.

2. Epstein AE, DiMarco JP, Ellenbogen KA, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2013;61(3):e6-e75. Available at https://www.ahajournals.org/lookup/doi/10.1161/CIR.0b013e318276ce9b. Last accessed December 8, 2020.


Copyright © 2021 NetCE, P.O. Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.